IIFL Securities's Stock Idea: Buy Max Healthcare Ins with Target Rs 1060

On September 20, IIFL Securities recommended buying Max Healthcare Ins shares with a target price of Rs 1060. The current market price of Max Healthcare Ins is Rs 1022.75, indicating a potential upside of 3.6%. IIFL Securities believes that the company's strong presence in the healthcare sector, experienced management team, and robust financial performance make it an attractive investment opportunity. Investors should consider this recommendation in light of their own financial situation and investment goals.

About Max Healthcare Ins:

Max Healthcare Institute Limited (Max Healthcare) is a leading provider of healthcare services in India. The company operates a network of 17 hospitals and 300 diagnostic centers across the country. Max Healthcare offers a range of medical services, including cardiology, oncology, orthopedics, and urology. The company is listed on the National Stock Exchange of India (NSE) and has a market capitalization of approximately $3 billion. Max Healthcare is part of the Max Group, a diversified conglomerate with interests in real estate, financial services, and manufacturing.

52 Week Price Trend:

Max Healthcare Ins(NSE:MAXHEALTH) is currently trading at Rs. 1022.75, which is within its 52-week range of Rs. 411.9 (low) to Rs. 910 (high). The stock has witnessed a significant rise in its value, gaining over 100% in the past year. This growth can be attributed to the company's strong financial performance and expansion plans. Analysts remain bullish on MAXHEALTH's prospects, expecting further gains in the near term. Its strong balance sheet, experienced management team, and growing healthcare market provide a favorable outlook for the company.

Stratzy's MOST Analysis:

Stratzy's MOST framework has rated MAXHEALTH with AA, indicating a medium fundamental risk. This rating is based on the company's management, outlook, safety, and trend. The company's strong management team, positive outlook, and stable financial performance contribute to its higher rating. However, potential risks or uncertainties in the industry or market may slightly impact the company's overall stability, resulting in the AA rating.

Company's Fundamentals:

Max Healthcare Ins (NSE:MAXHEALTH) is currently trading at a Stock PE of 76.78, indicating the number of years it would take for the company's earnings to equal its current stock price. Its PB Ratio of 10.34 suggests that the company's market value is 10.34 times its book value, providing insights into the company's asset valuation. Notably, MAXHEALTH offers a Dividend Yield of 0.12%, indicating the annual dividend paid out as a percentage of its stock price, providing investors with a potential income stream from their investment.

Fundamental and Technical information provided in this blog were last updated on 20 Sep, 2024

Disclaimer: The information and recommendations presented in this section, including any attached reports, are sourced from third-party providers through diverse channels. The views and opinions expressed within these materials belong solely to their respective creators. These views and opinions do not necessarily reflect the position of Stratzy Fintech Pvt Ltd. Stratzy explicitly disclaims any guarantees, express or implied, regarding the accuracy and reliability of the provided content. We strongly advise consulting with a licensed financial advisor before making any investment decisions based on this information. Remember, seeking independent financial advice is crucial.